Journal for immunotherapy of cancer · 2025
Protein catenation potentiates antitumor activity of malaria VAR2CSA navigation CAR-T cells in a mouse model of hematological malignancies.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hu Wen, Tao Zhu, Guo Wenzhong, Ding Wenting, Huang Shuozhou, Li Jiaojiao, Peng Huifeng, Zeng Liangwei, Chen Zhipeng, Qiu Runmin, Kang Zhongkui, Yao Yongchao, Chen Xiaoping
Аннотация
BACKGROUND: While CD19-targeting chimeric antigen receptor T-cell (CAR-T) therapies have shown efficacy in B-cell hematological malignancies, treatment of antigen-negative or relapsed tumors remains challenging. The recombinant malaria protein VAR2CSA (rVAR2) binds specifically to placental-like chondroitin sulfate A (pl-CSA), which is expressed on many cancer types, enabling its use in various tumor-targeting platforms. However, rVAR2-based CAR-T strategies are limited by poor protein thermostability, short serum half-life, and safety concerns related to irreversible CAR activation. To address these limitations, we developed a navigable CAR-T cell system that uses an rVAR2-based navigator to direct CAR-T cells to pl-CSA+ tumors.
METHODS: We overexpressed and purified rVAR2 and three catenation proteins in Escherichia coli, then produced and epitope-mapped the anti-rVAR2 monoclonal antibody 5H4VAR2omab following murine immunization. Using its single-chain fragment variable, we constructed a third-generation CAR-T with CD28 and 4-1BB co-stimulatory domains. An interlocking rVAR2 catenane, AXVB, was identified via orthogonal screening and employed as a navigator for directing CAR-T cells to pl-CSA+ tumors. The antitumor efficacy of this navigable CAR-T cell system was evaluated in vitro and in hematologic cancer cell line-derived xenograft models.
RESULTS: We developed an orthogonal CAR-T cell system that employs a navigator protein (rVAR2 or AXVB) to target pl-CSA+ tumors. Through a reversible switch mechanism, this system enables indirect tumor recognition by CAR-T cells, thereby improving the safety profile of conventional CAR-T therapies. Compared with the rVAR2 monomer, the AXVB multimer exhibited enhanced thermostability and target affinity. Both in vitro and in vivo, AXVB-(navigation)-CAR T cells potently eliminated CD19-positive and CD19-negative pl-CSA+ tumor cells and significantly prolonged survival in tumor-bearing mice.
CONCLUSIONS: Protein catenation improved the thermostability and functional activity of rVAR2. In a murine model of hematologic malignancy, CAR-T cells utilizing the rVAR2 catenane (AXVB) as a targeting module exhibited superior antitumor activity.
METHODS: We overexpressed and purified rVAR2 and three catenation proteins in Escherichia coli, then produced and epitope-mapped the anti-rVAR2 monoclonal antibody 5H4VAR2omab following murine immunization. Using its single-chain fragment variable, we constructed a third-generation CAR-T with CD28 and 4-1BB co-stimulatory domains. An interlocking rVAR2 catenane, AXVB, was identified via orthogonal screening and employed as a navigator for directing CAR-T cells to pl-CSA+ tumors. The antitumor efficacy of this navigable CAR-T cell system was evaluated in vitro and in hematologic cancer cell line-derived xenograft models.
RESULTS: We developed an orthogonal CAR-T cell system that employs a navigator protein (rVAR2 or AXVB) to target pl-CSA+ tumors. Through a reversible switch mechanism, this system enables indirect tumor recognition by CAR-T cells, thereby improving the safety profile of conventional CAR-T therapies. Compared with the rVAR2 monomer, the AXVB multimer exhibited enhanced thermostability and target affinity. Both in vitro and in vivo, AXVB-(navigation)-CAR T cells potently eliminated CD19-positive and CD19-negative pl-CSA+ tumor cells and significantly prolonged survival in tumor-bearing mice.
CONCLUSIONS: Protein catenation improved the thermostability and functional activity of rVAR2. In a murine model of hematologic malignancy, CAR-T cells utilizing the rVAR2 catenane (AXVB) as a targeting module exhibited superior antitumor activity.